R
e t rospective and prospective studies have demonstrated that hyperh o m ocysteinemia is a risk factor for pre m at u re cardiovascular disease (1,2) independent of other classic risk factors, such as smoking, h y p e rc h o l e s t e rolemia, arterial hypert e n s i o n , and diabetes (3). In fact, diabetes is an i m p o rtant risk factor not only for pre m a t u re a t h e ro s c l e rosis but also for its rapid pro g re ssion, because the risk of cardiovascular and peripheral vascular disease is associated with the metabolic abnormalities involved in diabetes (4). Moderate hyperh o m o c y s t e i n e m i a is common in the general population and has been linked with cardiovascular disease (5). The association of two risk factors for a t h e ro s c l e rosis, diabetes and hyperh o m ocysteinemia, strongly increases the risk of c a rdiovascular disease (6). Plasma totalhomocysteine (tHcy) has been studied in adult type 1 (4,7-9) and type 2 (8,10-13) diabetic patients, and moderate hyperh omocysteinemia was generally found. Fro m these studies, it was suggested that hyperhomocysteinemia contributes to the accelerated athero s c l e rotic process in diabetes (11). Recent studies concluded that diabetic patients with the lowest age at onset and the p o o rest metabolic control are the most p rone to developing a rapid increase in plasma tHcy (14) . However, no data are available about young type 1 diabetic p a t i e n t s .
Our aim was to study the presence of moderate hyperhomocysteinemia and its modifying factors (folates and vitamins B 1 2 and B 6 ) in adolescents with type 1 diabetes. We studied the possible re l a t i o n s h i p between hyperhomocysteinemia in type 1 diabetes and the duration of the disease, the d e g ree of metabolic control, the presence of m i c roalbuminuria, alterations in fundus oculi, and chronic lymphocytic thyro i d i t i s .
RESEARCH DESIGN AND M E T H O D S -
We studied 91 juvenile type 1 diabetic patients in treatment with a combination of short-acting (Actrapid) and i n t e rmediate-acting insulin (NPH) (injected twice a day), with a supplement of Actrapid when capillary glycemia becomes 1 0 mmol/l. The age range of our subjects was 11-18 years; sex was 46 girls and 45 boys. Since tHcy varied with age but not with sex in childhood and adolescence (15), the patients were classified in two age-gro u p s : 11-15 and 16-18 years (Table 1) . The duration of diabetes ranged from 1 to 15 years. All patients were in pubertal development stages III, IV, or V. Patients were also gro u p e d a c c o rding to the evolution time of the disease ( 5 years, n = 42; 5 years, n = 49). Complications of diabetes were taken into account, such as nonproliferative re t i n o p at h y, assessed by fluorescein angiography ( m i c ro a n e u rysms, n = 7); orthopedic exploration (camptodactily versus limited joint m o b i l i t y, n = 11); microalbuminuria, defined by a albumin/creatinine ratio 3 mg/mmol in the first morning urine; and association with thyroiditis (n = 7), diagnosed by e n l a rged thyroid gland and positive titers of t h y roid antibodies (antithyro p e ro x i d a s e antibodies 40 U/ml). R e f e rence values were derived fro m a p p a rently normal children and adolescents (by history and analytical data) who came to the laboratory for analytical contro l 
Total Homocysteine in Patients With Type 1 Diabetes O R I G I N A L A R T I C L E
O B J E C T I V E -Our aim was to study the presence of moderate hyperhomocysteinemia, a risk factor for pre m a t u re cardiovascular disease, its modifying vitamin factors (folates, vitamins B 1 2 and B 6 ), and lipid risk factors in juvenile type 1 diabetes.
RESEARCH DESIGN AND METHODS -A total of 91 patients with type 1 diabetes (46 girls and 45 boys) were studied, with ages ranging from 11 to 18 years, a duration of diabetes from 1 to 15 years, and in pubertal development (stages III, IV, V). In all patients, cholest e rol, triglycerides, HDL and LDL cholesterol, lipoprotein(a), folates, cobalamin, vitamin B 6 , and total homocysteine were determined by specific assays. Microalbuminuria, defined as a ratio of a l b u m i n / c reatinine 3 mg/mmol creatinine, was analyzed in the first morning specimen. . No significant diff e rences were found in tHcy values in re l a t i o n to the metabolic control of the disease as assessed by glycohemoglobin values, the duration of disease, alterations in fundus oculi, or presence of lymphocytic thyroiditis. A positive corre l ation was found between tHcy and plasma creatinine in type 1 diabetic patients that might be related with the increase in muscle mass. There was a negative correlation between tHcy and s e rum folate (P 0.001) and vitamin B 12 (P 0.05), but not with vitamin B 6 levels. No significant correlations were found between tHcy and the lipid parameters. Samples from the patients and the normal population for re f e rence values were collected following the Helsinki Declaration of 1975, as revised in 1983, and i n f o rmed consent was obtained from the families for the study.
R E S U LT S

C O N C L U S I O N S
Methods
Venous blood samples were collected after a 12-h fasting period from the antecubital vein to analyze a number of components. Blood glucose was measured by a glucose oxidase method, serum and urine cre a t i n i n e by a kinetic Jaffé reaction, and cholestero l and triglycerides by an enzymatic method (AU510; Merck, Darmstadt, Germ a n y ) . HDL cholesterol was measured enzymatically after precipitation of apolipopro t e i n B-containing lipoproteins with magnesium dextran sulphate; LDL cholesterol was calculated with the Friedewald formula; glycohemoglobin by high-perf o rmance liquid c h romatography (HPLC) (Auto A1c HA-8110; Menarini, Firenze, Italy); folates and cobalamin by radioassay using purified intrinsic factor and purified folate binding p rotein (Simultrac; Becton Dickinson, O r a n g e b u rg, NY) with a Co/Gamma Counter (LKB Wallac 1272; Cambridge, U.K.); vitamin B 6 by HPLC (Integral 4000; Perkin Elmer, Beaconsfield, U.K.) with fluo rescence detection (LC 240, Chro m s y stem Kit; Chromsystems Instruments & Chemicals GmbH, Mart i n s reid, Germ a n y ) ; total homocysteine by HPLC with fluore scence detection of the SBDF derivatives (Sigma Chemicals, St. Louis, MO) (15); urin a ry albumin by nefelometry (Behring BNA Nefelometer; Behring, Marburg ,G e rm a n y ) . U r i n a ry albumin and creatinine concentration were measured in the first morn i n g s p e c i m e n .
Statistics
Since tHcy values did not follow a Gaussian distribution, results are presented as median and range. All statistical tests were twotailed, and a 5% level of significance was used to evaluate diff e rences. Nonparametric Mann-Whitney U test was applied in the case of two independent samples and Spearm a n ' s rank correlation coefficient test was used to test for monovariate re l a t i o n s h i p s between diff e rent variables.
R E S U LT S -Plasma total homocysteine
concentrations were not diff e rent between our patients with diabetes-aged 11-15 years, 6.1 (3.2-9.6) µmol/l, median ( r a n g e ) ; aged 16-18 years, 7.3 (3.9-12) µmol/land our control group-aged 11-15 years, 6.6 (4.4-10.8) µmol/l; 16-18 years, 8.1 (4.6-11.3) µmol/l (Mann-Whitney U t e s t ) (Fig. 1) . No significant diff e rences were found between tHcy values in relation to 11.5 (4.2-33.5) 3 . 6 -1 8 tHcy (µmol/l) 11-15 years 6.1 (3.2-9.6) 4 . 4 -1 0 . 8 16-18 years 7.3 (3.9-12) 4 . 6 -1 1 . 3 Albuminuria (mg/mmol cre a t i n i n e ) 3 . 0 3 . 0 Data are n, range, median (range), or median.
F i g u re 1-Multiple box-plot of plasma tHcy in juvenile type 1 diabetes (DM) versus re f e rence values (RV ) .
Homocysteine in diabetes the evolution time of the disease, metabolic control, or the presence of micro an e u rysms in fundus oculi or of lymphocytic t h y roiditis (Table 2) . Values for micro a l b uminuria, expressed as albumin/cre a t i n i n e ratio, were 3 mg/mmol in all patients ( Tables 1 and 2) .
A positive correlation was found between total homocysteine and plasma creatinine (r = 0.43, P 0.0001). There was a negative correlation between tHcy and s e rum folate (r = 0.33, P 0.001) and vitamin B 1 2 (r = 0.23, P 0.05), while no significant correlation was found between plasma tHcy and vitamin B 6 levels. There w e re no significant correlations between tHcy and the lipid parameters studied.
C O N C L U S I O N S -Plasma tHcy values
a re determined by genetic and nutritional factors. Deficient activities of the enzymes of the trans-sulfuration and remethylation pathways, as well as a common mutation (C677T) causing a thermolabile variant of the enzyme methylenetetrahydro f o l a t e reductase, may cause hyperh o m o c y s t e i n emia. More o v e r, three vitamins involved in homocysteine metabolism as coenzymes (vitamins B 1 2 and B 6 ) and substrate (folate) are i m p o rtant determinants of plasma tHcy, especially folate (16). There f o re, determ i n ation of these modifying factors is needed in evaluating the presence of hyperh o m o c y steinemia and its possible etiology. In our patients, vitamin levels were within the normal range, suggesting that no nutritional p roblems affecting vitamin levels had altere d tHcy values despite the diet followed for their diabetes.
Considering tHcy studies in diabetic patients, hyperhomocysteinemia seems to be associated with the clinical manifestations of macroangiopathy (10) and pro l i f e rative retinopathy (9), while other re s e a rc h e r s found high tHcy levels only in patients with clinical signs of diabetic nephropathy (11). They found no association between plasma tHcy and diff e rent degrees of re t i n o p a t h y, so t h rough further studies they concluded that tHcy does not play a major role in the prog ression of diabetic retinopathy (14). In another study (8), only diabetic patients with macroangiopathy and nephro p a t h y (and even those with only proteinuria or m i c roalbuminuria) showed hyperh o m o c y steinemia, but not diabetic patients without renal insuff i c i e n c y. Only one author found low tHcy concentrations in adult patients with type 1 diabetes and micro a l b u m i nuria, perhaps by comparing them with a nonhomogeneous control sample (7). Our study showed no diff e rences in tHcy levels between patients and re f e rence values. None of our patients had developed m i c roalbuminuria, and folate levels were high in all of them as an index of good nutritional status. No association was found between tHcy and other risk factors for cardiovascular disease. Only creatinine values showed an association with tHcy concentrations. This finding might reflect the i n c rease of creatinine synthesis during p u b e rt y, secondary to the development of muscle mass. Other authors concluded that neither type 1 diabetes nor diabetic retinopathy per se is associated with hyperhomocysteinemia, which would only depend on impaired renal function (4,17). Homocysteine metabolism is especially i m p o rtant in renal parenchyma (18) and is a l t e red in early stages of impaired re n a l function, depending on individual genetic and nutritional factors (17). In our patients, no alteration in renal function was o b s e rved, so this possibility seems an unlikely explanation.
The special interest of the study of plasma tHcy in diabetes lies in the possibility of easily correcting hyperh o m o c y s t e i n emia by supplementation with low folate doses (2, 14) . Although tHcy values seem still to be normal in diabetic adolescents, they may become higher in adults in association with renal impairment and low blood folate levels (14), especially in people carrying the C677T mutation (13). The corre l ation of tHcy values with folate found in our patients and in most other studies (10,14) c o n f i rms the relationship between the two parameters. People with diabetes may re q u i re additional folate intake to avoid the combined risk factors for athero s c l e rosis that s t rongly increase the risk for card i o v a s c u l a r disease (6). The search for hyperh o m o c y steinemia in adult diabetic patients and the possibility of folate supplementation seems t h e re f o re very useful, as has also been suggested by other authors (19).
In conclusion, hyperh o m o c y s t e i n e m i a was not detected in juvenile type 1 diabetes, at least in the age range studied, and seems to have no predictive value per se for c a rdiovascular disease.
